Machine Learning vs Traditional Approaches to Predict All-Cause Mortality for Acute Coronary Syndrome: A Systematic
Aashray K Gupta1, Cecil Mustafiz2, Daud Mutahar3
1Discipline of Surgery, University of Adelaide, Adelaide, Australia.
The Canadian Journal of Cardiology
|February 19, 2025
Summary
Machine learning models show superior accuracy in predicting mortality for acute coronary syndrome (ACS) patients compared to traditional risk scores. Further validation is needed for widespread clinical use of these advanced models.
Area of Science:
- Cardiology
- Medical Informatics
- Data Science
Background:
- Acute coronary syndrome (ACS) is a leading global cause of mortality.
- Accurate risk prediction is crucial for effective ACS patient management and treatment.
- Existing risk stratification models (e.g., GRACE, TIMI) have limitations in predictive accuracy.
Purpose of the Study:
- To compare the performance of machine learning (ML) models against traditional risk scores for predicting all-cause mortality in ACS patients.
- To evaluate the discriminative value of ML models in ACS prognosis.
- To synthesize evidence on the comparative effectiveness of ML in ACS risk stratification.
Main Methods:
- Systematic review and meta-analysis of studies comparing ML models and traditional methods for ACS mortality prediction.
- Searched multiple databases (PubMed, Embase, Web of Science, etc.) up to October 30, 2024.
- Primary outcome: comparative discrimination measured by C-statistics.
Main Results:
- Twelve studies involving 250,510 patients were analyzed.
- ML models achieved a summary C-statistic of 0.88, outperforming traditional methods (0.82).
- ML models demonstrated significantly superior discrimination for all-cause mortality in ACS patients.
Conclusions:
- Machine learning models offer improved risk prediction for ACS mortality compared to established tools.
- Despite superior performance, clinical application of ML models requires further validation due to identified risks of bias.
- Future research should focus on robust validation of ML models for reliable clinical implementation in ACS care.


